Response to Letter Regarding Article, “Effect of Tumor Necrosis Factor Inhibitor Treatment on Proximal Right Coronary Chronic Total Occlusion in a Patient With Rheumatoid Arthritis”

Total Occlusion ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Letter by Seropian and Abbate Regarding Article, “Effect of Tumor Necrosis Factor Inhibitor Treatment on Proximal Right Coronary Chronic Total Occlusion in a Patient With Rheumatoid Arthritis”

Circulation ◽

10.1161/circulationaha.115.015865 ◽

2015 ◽

Vol 132 (13) ◽

Author(s):

Ignacio M. Seropian ◽

Antonio Abbate

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Chronic Total Occlusion ◽

Tumor Necrosis ◽

Total Occlusion ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Effect of Tumor Necrosis Factor Inhibitor Treatment on Proximal Right Coronary Chronic Total Occlusion in a Patient With Rheumatoid Arthritis

Circulation ◽

10.1161/circulationaha.114.012900 ◽

2015 ◽

Vol 131 (4) ◽

Cited By ~ 4

Author(s):

Michael Behnes ◽

Ibrahim Akin ◽

Martin Borggrefe ◽

Dominik Traunwieser ◽

Hans Neuser ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Chronic Total Occlusion ◽

Tumor Necrosis ◽

Total Occlusion ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Successful cessation of tumor necrosis factor inhibitor treatment in rheumatoid arthritis patients and potential predictors for early flare: An observational study in routine clinical care

Modern Rheumatology ◽

10.1080/14397595.2019.1702253 ◽

2020 ◽

Vol 30 (6) ◽

pp. 948-958

Author(s):

Taio Naniwa ◽

Shiho Iwagaitsu ◽

Mikiko Kajiura

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Observational Study ◽

Tumor Necrosis ◽

Clinical Care ◽

Routine Clinical Care ◽

Factor Inhibitor ◽

Necrosis Factor ◽

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity

Arthritis & Rheumatology ◽

10.1002/art.40546 ◽

2018 ◽

Vol 70 (10) ◽

pp. 1557-1564 ◽

Cited By ~ 6

Author(s):

An Tran-Duy ◽

Marjan Ghiti Moghadam ◽

Martijn A. H. Oude Voshaar ◽

Harald E. Vonkeman ◽

Annelies Boonen ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Economic Evaluation ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Low Disease Activity ◽

Disease Remission ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden area

Clinical Rheumatology ◽

10.1007/s10067-013-2387-z ◽

2013 ◽

Vol 33 (9) ◽

pp. 1307-1312 ◽

Cited By ~ 13

Author(s):

Hye Won Kim ◽

Jin Kyun Park ◽

Ji-Ae Yang ◽

Young Im Yoon ◽

Eun Young Lee ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Ankylosing Spondylitis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tuberculosis Incidence ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Comparison of Glucocorticoid and Nonsteroidal Anti-Inflammatory Drug Requirement Before and After Tumor Necrosis Factor Inhibitor Treatment in Patients With Rheumatoid Arthritis

Archives of Rheumatology ◽

10.5606/archrheumatol.2015.5504 ◽

2015 ◽

Vol 30 (3) ◽

pp. 206-213

Author(s):

Merih Birlik

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Inflammatory Drug ◽

Before And After ◽

Factor Inhibitor ◽

Drug Requirement ◽

Necrosis Factor ◽

Reversal of Transfusion Dependence by Tumor Necrosis Factor Inhibitor Treatment in a Patient With Concurrent Rheumatoid Arthritis and Primary Myelofibrosis

JCR Journal of Clinical Rheumatology ◽

10.1097/rhu.0b013e31821c7ef6 ◽

2011 ◽

Vol 17 (Suppl 1) ◽

pp. 211-213 ◽

Cited By ~ 4

Author(s):

Anderson Ong ◽

Hang Quach ◽

Michelle Leech

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Primary Myelofibrosis ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment

BMC Rheumatology ◽

10.1186/s41927-019-0071-x ◽

2019 ◽

Vol 3 (1) ◽

Author(s):

Marjan Ghiti Moghadam ◽

◽

Femke B. G. Lamers-Karnebeek ◽

Harald E. Vonkeman ◽

Peter M. ten Klooster ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Disease Control ◽

Tumor Necrosis ◽

Factor Inhibitor ◽

Necrosis Factor ◽

Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2015.02.004 ◽

2015 ◽

Vol 72 (5) ◽

pp. 917-919 ◽

Cited By ~ 5

Author(s):

Jashin J. Wu ◽

Christopher G. Rowan ◽

Judith D. Bebchuk ◽

Mary S. Anthony

Keyword(s):

Rheumatoid Arthritis ◽

Blood Pressure ◽

Psoriatic Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

C Reactive Protein ◽

Reactive Protein ◽

Factor Inhibitor ◽

Necrosis Factor

Economic Burden of Switching to a Non-Tumor Necrosis Factor Inhibitor Versus a Tumor Necrosis Factor Inhibitor Biologic Therapy among Patients with Rheumatoid Arthritis

Advances in Therapy ◽

10.1007/s12325-016-0318-5 ◽

2016 ◽

Vol 33 (5) ◽

pp. 807-823 ◽

Cited By ~ 9

Author(s):

Zheng-Yi Zhou ◽

Jenny Griffith ◽

Ella Xiaoyan Du ◽

Daniel Chin ◽

Keith A. Betts ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Economic Burden ◽

Tumor Necrosis ◽

Biologic Therapy ◽

Factor Inhibitor ◽

Necrosis Factor